TREATMENT VARIATION AND ITS IMPLICATION FOR SEVERE FONTAN-ASSOCIATED PROTEIN LOSING ENTEROPATHY

There are no guidelines for treatment of Fontan-associated protein-losing enteropathy (PLE). This multicenter study aimed to characterize PLE treatment patterns and outcomes. This 12-center, retrospective cohort study of all post-Fontan patients (pts) with PLE referred for heart transplant (HTx)